Clinical Trials Logo
  1. Home
  2. Inflammatory Bowel Disease (IBD)
  3. NCT02256605

Vitamin D3 Supplementation in Pediatric IBD: Weely vs Daily Dosing Regimens

Inflammatory Bowel Disease (IBD) Clinical Trial

Clinical Trial Summary

The purpose of this prospecitve randomized controlled trial is to compare effectiveness and patient/family adherence of weekly or daily Vitamin D-3 dosing regimens in children with Inflammatory Bowel Disease (IBD) who are 25-hydroxyvitamin D [25(OH)D] insufficient or deficient. The primary aim of this pilot study is to evaluate the effectiveness of once weekly verses daily D-3 dosing regimens based on the most current IBD supplementation guidelines in improving 25(OH)D levels. A seconary aim is to determine if there is difference in adherence between dosing regimns.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02256605
Study type Observational
Source Nemours Children's Clinic
Contact
Status Completed
Phase N/A
Start date November 2013
Completion date May 2015
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05428345 - A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
Completed NCT02265588 - Healthy Approach to Physical and Psychological Problems in Youngsters With IBD (HAPPY-IBD). N/A
Completed NCT01022749 - Efficacy Safety Study of Flu Vaccine in Immunodepression Patients Phase 3
Completed NCT02461758 - Trial of High Dose vs. Standard Dose Influenza Vaccine in Inflammatory Bowel Disease Patients Phase 4
Completed NCT01095042 - Cognition and Emotion in the SII and IBD N/A
Completed NCT00542776 - Impact of Immunosuppression in IBD Patients on Response to Influenza Vaccine N/A
Completed NCT02778464 - Faecal Calprotectin as a Potential Non-invasive Inflammatory Marker in Pregnancy and Inflammatory Bowel Disease
Recruiting NCT05078879 - Empagliflozin as a Treatment for Severe Congenital Neutropenia Due to G6PC3 Deficiency Phase 1
Completed NCT05596422 - A Study of Vedolizumab and Biologic Agents in Participants With Inflammatory Bowel Disease (IBD)
Completed NCT02355834 - Faecal Incontinence iNtervention Study N/A
Not yet recruiting NCT01852097 - An Online Intervention to Address Barriers to IBD Medication Adherence N/A
Terminated NCT00325078 - Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease Phase 1/Phase 2
Terminated NCT03886753 - Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products
Recruiting NCT04345393 - Translating Scientific Evidence Into Practice Using Digital Medicine and Electronic Patient Reported Outcomes N/A
Completed NCT01819766 - Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease N/A
Completed NCT01560819 - Gut Microbial Transplantation in Pediatric Inflammatory Bowel Diseases Phase 1
Completed NCT00820365 - SC12267 (4SC-101) for Treatment of Patients With Inflammatory Bowel Disease Phase 2
Completed NCT02156557 - Study of KCC Peptide Application in the Colon Phase 1
Completed NCT01364896 - Anal Human Papillomavirus in Inflammatory Bowel Disease Study
Terminated NCT00152620 - Dexamethasone Versus Methylprednisolone for the Treatment of Active Inflammatory Bowel Disease N/A